Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Pick Your #1 Sort Of Espresso - 2UK forecast to face weaker growth and higher inflation from Iran war
- 3Emergent Cold LatAm opens state-of-the-art cold storage hub in Guadalajara
- 4Deadly Switzerland ski resort fire was likely started by sparklers attached to champagne bottles, officials say
- 5Share your pick for the tree that you love for its novel magnificence!
- What we know about Jonathan Ross, the ICE agent who shot and killed Renee Nicole Good in Minneapolis
- Poll: 62% of Americans would oppose U.S. military action in Greenland
- As her kidneys fail and time runs short, this activist fights to decriminalize euthanasia in Mexico
- Exploring ways to reduce the impact of space junk on Earth
- Supreme Court case about ‘crisis pregnancy centers’ highlights debate over truthful advertising standards
- Remote Headphones: Upgrade Your Sound Insight
- Photos: Hundreds Gather at Bondi Beach After Deadly Attack
- Which game do you cherish observing live? Vote!
- Ten Awesome Authentic Realities That Will Leave You Interested
